Enza Lacivita

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

Journal of medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

ACS chemical neuroscience

Cells

Università degli Studi di Bari Aldo Moro

Università degli Studi di Bari Aldo Moro (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Bari Aldo Moro Feb 17 2017

Italy

Associate Professor :: Dipartimento di Farmacia-Scienze del Farmaco

Università degli Studi di Bari Aldo Moro Feb 01 2005 - Feb 16 2017

Italy

Assistant Professor :: Dipartimento di Farmacia-Scienze del Farmaco

Education History

Università degli Studi di Bari Aldo Moro Nov 01 1997 - Jan 21 2001

Italy

PHD :: Dipartimento Farmaco-Chimico

Publications

Leonardo Brunetti, Fabio Francavilla, Marcello Leopoldo, Enza Lacivita
Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Leonardo Brunetti, Fabio Francavilla, Marcello Leopoldo, Enza Lacivita
Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Kinga Tylek, Ewa Trojan, Monika Leśkiewicz, Fabio Francavilla, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim
Stimulation of Formyl Peptide Receptor-2 by the New Agonist CMC23 Protects against Endotoxin-Induced Neuroinflammatory Response: A Study in Organotypic Hippocampal Cultures. ACS chemical neuroscience (2023)
Kinga Tylek, Ewa Trojan, Monika Leśkiewicz, Imane Ghafir El Idrissi, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim
Microglia Depletion Attenuates the Pro-Resolving Activity of the Formyl Peptide Receptor 2 Agonist AMS21 Related to Inhibition of Inflammasome NLRP3 Signalling Pathway: A Study of Organotypic Hippocampal Cultures. Cells 12 (21) (2023)
Margherita Mastromarino, Maria Favia, Igor A Schepetkin, Lylia N Kirpotina, Ewa Trojan, Mauro Niso, Antonio Carrieri, Monika Leśkiewicz, Magdalena Regulska, Massimiliano Darida, Francesco Rossignolo, Stefano Fontana, Mark T Quinn, Agnieszka Basta-Kaim, Marcello Leopoldo, Enza Lacivita
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders. Journal of medicinal chemistry 65 (6) (2022)
Eduardo Penna, Mauro Niso, Sabina Podlewska, Floriana Volpicelli, Marianna Crispino, Carla Perrone-Capano, Andrzej J Bojarski, Enza Lacivita, Marcello Leopoldo
In Vitro and In Silico Analysis of the Residence Time of Serotonin 5-HT 7 Receptor Ligands with Arylpiperazine Structure: A Structure-Kinetics Relationship Study. ACS chemical neuroscience 13 (4) (2022)
Margherita Mastromarino, Mauro Niso, Carmen Abate, Ewgenij Proschak, Mariam Dubiel, Holger Stark, Marián Castro, Enza Lacivita, Marcello Leopoldo
Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties. Molecules (Basel, Switzerland) 27 (4) (2022)
Claudia Cristiano, Floriana Volpicelli, Marianna Crispino, Enza Lacivita, Roberto Russo, Marcello Leopoldo, Antonio Calignano, Carla Perrone-Capano
Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Robert W Garvey, Enza Lacivita, Mauro Niso, Beata Duszyńska, Paul E Harris, Marcello Leopoldo
Design, Synthesis, and Characterization of a Novel Fluoroprobe for Live Human Islet Cell Imaging of Serotonin 5-HT 1A Receptor. ChemMedChem 17 (10) (2022)
Kinga Tylek, Ewa Trojan, Magdalena Regulska, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim
Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology. Pharmacological reports : PR 73 (4) (2021)
Francesca Serena Abatematteo, Mauro Niso, Enza Lacivita, Carmen Abate
σ2 Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach. Molecules (Basel, Switzerland) 26 (12) (2021)
Ewa Trojan, Kinga Tylek, Nicole Schröder, Iris Kahl, Lars-Ove Brandenburg, Margherita Mastromarino, Marcello Leopoldo, Agnieszka Basta-Kaim, Enza Lacivita
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease. Molecular neurobiology 58 (12) (2021)
Ewa Trojan, Kinga Tylek, Monika Leśkiewicz, Władysław Lasoń, Lars-Ove Brandenburg, Marcello Leopoldo, Enza Lacivita, Agnieszka Basta-Kaim
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Exhibits Anti-Inflammatory Activity in LPS-Stimulated Organotypic Hippocampal Cultures. Cells 10 (6) (2021)
Enza Lacivita, Mauro Niso, Margherita Mastromarino, Andrea Garcia Silva, Cibell Resch, Andre Zeug, María I Loza, Marián Castro, Evgeni Ponimaskin, Marcello Leopoldo
Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder. ACS chemical neuroscience 12 (8) (2021)
Sabina Podlewska, Ryszard Bugno, Enza Lacivita, Marcello Leopoldo, Andrzej J Bojarski, Jadwiga Handzlik
Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2. International journal of molecular sciences 22 (3) (2021)
Kinga Tylek, Ewa Trojan, Monika Leśkiewicz, Magdalena Regulska, Natalia Bryniarska, Katarzyna Curzytek, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim
Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways. Cells 10 (9) (2021)
Alessandra Tempio, Mauro Niso, Luna Laera, Lucia Trisolini, Maria Favia, Lucia Ciranna, Domenico Marzulli, Giuseppe Petrosillo, Ciro Leonardo Pierri, Enza Lacivita, Marcello Leopoldo
Mitochondrial Membranes of Human SH-SY5Y Neuroblastoma Cells Express Serotonin 5-HT7 Receptor. International journal of molecular sciences 21 (24) (2020)
Margherita Mastromarino, Liliya N Kirpotina, Igor A Schepetkin, Mark T Quinn, Enza Lacivita, Marcello Leopoldo
Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists. MedChemComm 10 (12) (2019)
Maria N Modica, Enza Lacivita, Sebastiano Intagliata, Loredana Salerno, Giuseppe Romeo, Valeria Pittala, Marcello Leopoldo
Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update. Journal of medicinal chemistry 61 (19) (2018)
Ermelinda Lucente, Hongguang Liu, Yang Liu, Xiang Hu, Enza Lacivita, Marcello Leopoldo, Zhen Cheng
Novel 64Cu Labeled RGD2-BBN Heterotrimers for PET Imaging of Prostate Cancer. Bioconjugate chemistry 29 (5) (2018)
Enza Lacivita, Roberto Perrone, Lucia Margari, Marcello Leopoldo
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions. Journal of medicinal chemistry 60 (22) (2017)
Madia L Stama, Enza Lacivita, Liliya N Kirpotina, Mauro Niso, Roberto Perrone, Igor A Schepetkin, Mark T Quinn, Marcello Leopoldo
Functional N-Formyl Peptide Receptor 2 (FPR2) Antagonists Based on the Ureidopropanamide Scaffold Have Potential To Protect Against Inflammation-Associated Oxidative Stress. ChemMedChem 12 (22) (2017)

Enza Lacivita.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Enza Lacivita